These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23528517

  • 1. Bradykinin B₁ antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system.
    Catanzaro O, Capponi JA, Michieli J, Labal E, Di Martino I, Sirois P.
    Peptides; 2013 Jun; 44():100-4. PubMed ID: 23528517
    [Abstract] [Full Text] [Related]

  • 2. Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R-954.
    Catanzaro O, Labal E, Andornino A, Capponi JA, Di Martino I, Sirois P.
    Peptides; 2012 Apr; 34(2):349-52. PubMed ID: 22369720
    [Abstract] [Full Text] [Related]

  • 3. [The role of oxidative stress in experimental diabetic neuropathy].
    Wang L, Zheng KJ, Dong DY, Sun Y, Wang YM.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):108-11. PubMed ID: 21141571
    [Abstract] [Full Text] [Related]

  • 4. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
    Liu Y, Wang L, Li X, Lv C, Feng D, Luo Z.
    Biochem Biophys Res Commun; 2010 Aug 13; 399(1):49-54. PubMed ID: 20637731
    [Abstract] [Full Text] [Related]

  • 5. Oxidative stress in the optic nerve and cortical visual area of steptozotocin-induced diabetic Wistar rats: Blockade with a selective bradykinin B1 receptor antagonist.
    Catanzaro OL, Capponi JA, Di Martino I, Labal ES, Sirois P.
    Neuropeptides; 2017 Dec 13; 66():97-102. PubMed ID: 29089149
    [Abstract] [Full Text] [Related]

  • 6. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
    Lawson SR, Gabra BH, Nantel F, Battistini B, Sirois P.
    Eur J Pharmacol; 2005 May 02; 514(1):69-78. PubMed ID: 15878326
    [Abstract] [Full Text] [Related]

  • 7. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy.
    Kamboj SS, Vasishta RK, Sandhir R.
    J Neurochem; 2010 Jan 02; 112(1):77-91. PubMed ID: 19840221
    [Abstract] [Full Text] [Related]

  • 8. Diltiazem attenuates oxidative stress in diabetic rats.
    Anjaneyulu M, Chopra K.
    Ren Fail; 2005 Jan 02; 27(3):335-44. PubMed ID: 15957552
    [Abstract] [Full Text] [Related]

  • 9. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
    Han LP, Yu DM, Xie Y.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2513-5. PubMed ID: 19080636
    [Abstract] [Full Text] [Related]

  • 10. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sharma SS, Sayyed SG.
    Clin Exp Pharmacol Physiol; 2006 Nov 16; 33(11):1022-8. PubMed ID: 17042909
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment of silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat.
    Baluchnejadmojarad T, Roghani M, Khastehkhodaie Z.
    Phytother Res; 2010 Aug 16; 24(8):1120-5. PubMed ID: 19960427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 receptor antagonist.
    Gabra BH, Benrezzak O, Pheng LH, Duta D, Daull P, Sirois P, Nantel F, Battistini B.
    J Neuropathol Exp Neurol; 2005 Sep 16; 64(9):782-9. PubMed ID: 16141788
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of Cleome viscosa on hyperalgesia, oxidative stress and lipid profile in STZ induced diabetic neuropathy in Wistar rats.
    Rao BS, Reddy KE, Parveen K, Narendra BL, Shekhar SC, Mangala L.
    Pak J Pharm Sci; 2014 Sep 16; 27(5):1137-45. PubMed ID: 25176371
    [Abstract] [Full Text] [Related]

  • 17. Antidiabetic efficacy of bradykinin antagonist R-954 on glucose tolerance test in diabetic type 1 mice.
    Catanzaro OL, Dziubecki D, Obregon P, Rodriguez RR, Sirois P.
    Neuropeptides; 2010 Apr 16; 44(2):187-9. PubMed ID: 20092893
    [Abstract] [Full Text] [Related]

  • 18. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
    Obrosova IG, Fathallah L, Stevens MJ.
    Exp Neurol; 2001 Nov 16; 172(1):211-9. PubMed ID: 11681853
    [Abstract] [Full Text] [Related]

  • 19. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG, Kumar A, Sharma SS.
    Life Sci; 2006 Jul 17; 79(8):777-83. PubMed ID: 16581090
    [Abstract] [Full Text] [Related]

  • 20. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model.
    Valsecchi AE, Franchi S, Panerai AE, Rossi A, Sacerdote P, Colleoni M.
    Eur J Pharmacol; 2011 Jan 15; 650(2-3):694-702. PubMed ID: 21050844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.